Article: Noninvasive imaging may show telomerase promoter activity in humans.

Article: Geron's Telomerase Promoter to be Highlighted At ...
Business Wire;  May 30, 2002 ;     700+ words ... ... controlled by the telomerase promoter, can effectively ... Association for Cancer Research held in April ... telomerase and the telomerase promoter. These positive ... with our telomerase promoter technology ... telomerase and cancer research since the ...

Article: Geron Corporation Announces Study Results Demonstrating the ...
Business Wire;  April 5, 2001 ;     700+ words ... ... demonstrates the utility of the human telomerase promoter to drive the preferential expression ... April 4 issue of Gene Therapy, the telomerase promoter, which drives the restricted expression ... therapeutic gene under control of the telomerase promoter killed the cancer cells ...

Article: Telomerase promoter gene therapy jumpstarts lung ...
Science Letter;  September 21, 2004 ;     700+ words ... ... NewsRx.com & NewsRx.net) -- Telomerase promoter gene therapy jumpstarts lung cancer cell apoptosis ... mediated HSV-TK gene therapy using the human telomerase promoter induced apoptosis of small cell lung cancer ...

Article: Study Demonstrates Utility of Telomerase ...
Biotech Week;  April 18, 2001 ;     700+ words ... ... net) -- Geron Corp. (GERN) announced the publication of a study that demonstrates the utility of the human telomerase promoter to drive the preferential expression of therapeutic genes in cancer cells. The research, described in the April ...

Article: Study Demonstrates Utility of Telomerase Promoter.
Gene Therapy Weekly;  April 19, 2001 ;     700+ words ... ... net) -- Geron Corp. (GERN) announced the publication of a study that demonstrates the utility of the human telomerase promoter to drive the preferential expression of therapeutic genes in cancer cells. The research, described in the April ...

Article: Geron Receives U.S. Patent for Human Telomerase ...
Business Wire;  August 26, 2003 ;     700+ words ... ... Cell Genesys' Senior Vice President of Corporate Development. "Our scientists have a strong interest in the telomerase promoter and we are eager to continue working with it in our oncolytic virus research in order to identify a clinical candidate ...

Article: Geron wins patent for human telomerase promoter, ...
Gene Therapy Weekly;  September 25, 2003 ;     700+ words ...2003 SEP 25 - (NewsRx.com & NewsRx.net) -- Geron Corp. (GERN) announced that it has been granted U.S. patent no. 6,610,839, by the U.S. Patent and Trademark Office, with claims covering the promoter that regulates expression of the human telomerase reverse transcriptase gene (the "hTERT